Literature DB >> 18321505

Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy.

Douglas Ashley Monks1, Pengcheng Rao, Kaiguo Mo, Jamie Ann Johansen, Gareth Lewis, Michael Quentin Kemp.   

Abstract

Kennedy Disease/Spinal Bulbar Muscular Atrophy (KD/SBMA) is a progressive neurodegenerative disease caused by genetic polyglutamine expansion of the androgen receptor. We have recently found that overexpression of wildtype androgen receptor in skeletal muscle of transgenic mice results in a KD/SBMA phenotype. This surprising result challenges the orthodox view that KD/SBMA requires expression of polyglutamine expanded androgen receptor within motoneurons. Theories relating to the etiology of this disease drawn from studies of human patients, cellular and mouse models are considered with a special emphasis on potential myogenic contributions to as well as the molecular etiology of KD/SBMA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321505      PMCID: PMC2883265          DOI: 10.1016/j.yhbeh.2007.12.009

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  76 in total

1.  Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor.

Authors:  Andrew P Lieberman; George Harmison; Andrew D Strand; James M Olson; Kenneth H Fischbeck
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

2.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

3.  Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; D B Roling; A E Harding; C L Warner; R Spiegel; I Hausmanowa-Petrusewicz; W C Yee; K H Fischbeck
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

4.  Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.

Authors:  Masahisa Katsuno; Hiroaki Adachi; Akito Kume; Mei Li; Yuji Nakagomi; Hisayoshi Niwa; Chen Sang; Yasushi Kobayashi; Manabu Doyu; Gen Sobue
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

5.  Hormonal control of neuron number in sexually dimorphic spinal nuclei of the rat: II. Development of the spinal nucleus of the bulbocavernosus in androgen-insensitive (Tfm) rats.

Authors:  D R Sengelaub; C L Jordan; E M Kurz; A P Arnold
Journal:  J Comp Neurol       Date:  1989-02-22       Impact factor: 3.215

6.  A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat.

Authors:  W G Yarbrough; V E Quarmby; J A Simental; D R Joseph; M Sar; D B Lubahn; K L Olsen; F S French; E M Wilson
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

7.  Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice.

Authors:  P M Bingham; M O Scott; S Wang; M J McPhaul; E M Wilson; J Y Garbern; D E Merry; K H Fischbeck
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

8.  Ciliary neurotrophic factor maintains motoneurons and their target muscles in developing rats.

Authors:  N G Forger; S L Roberts; V Wong; S M Breedlove
Journal:  J Neurosci       Date:  1993-11       Impact factor: 6.167

9.  A mouse model of spinal and bulbar muscular atrophy.

Authors:  Patrick McManamny; Hun S Chy; David I Finkelstein; Rebecca G Craythorn; Peter J Crack; Ismail Kola; Surindar S Cheema; Malcolm K Horne; Nigel G Wreford; Moira K O'Bryan; David M De Kretser; John R Morrison
Journal:  Hum Mol Genet       Date:  2002-09-01       Impact factor: 6.150

10.  Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice.

Authors:  K J Brennan; E C Hardeman
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

View more
  10 in total

1.  A tetracycline-inducible and skeletal muscle-specific Cre recombinase transgenic mouse.

Authors:  Pengcheng Rao; D Ashley Monks
Journal:  Dev Neurobiol       Date:  2009-05       Impact factor: 3.964

2.  Androgens in health and disease: an overview.

Authors:  Cynthia L Jordan; Lydia Doncarlos
Journal:  Horm Behav       Date:  2008-03-06       Impact factor: 3.587

3.  Myocyte androgen receptors increase metabolic rate and improve body composition by reducing fat mass.

Authors:  Shannon M Fernando; Pengcheng Rao; Lee Niel; Diptendu Chatterjee; Marijana Stagljar; D Ashley Monks
Journal:  Endocrinology       Date:  2010-04-28       Impact factor: 4.736

4.  Rare diseases in clinical endocrinology: a taxonomic classification system.

Authors:  G Marcucci; L Cianferotti; P Beck-Peccoz; M Capezzone; F Cetani; A Colao; M V Davì; E degli Uberti; S Del Prato; R Elisei; A Faggiano; D Ferone; C Foresta; L Fugazzola; E Ghigo; G Giacchetti; F Giorgino; A Lenzi; P Malandrino; M Mannelli; C Marcocci; L Masi; F Pacini; G Opocher; A Radicioni; M Tonacchera; R Vigneri; M C Zatelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  2014-11-07       Impact factor: 4.256

5.  Resistance strength training exercise in children with spinal muscular atrophy.

Authors:  Aga Lewelt; Kristin J Krosschell; Gregory J Stoddard; Cindy Weng; Mei Xue; Robin L Marcus; Eduard Gappmaier; Louis Viollet; Barbara A Johnson; Andrea T White; Donata Viazzo-Trussell; Philippe Lopes; Robert H Lane; John C Carey; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2015-10       Impact factor: 3.217

6.  Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy.

Authors:  Kaiguo Mo; Zak Razak; Pengcheng Rao; Zhigang Yu; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Andrew P Lieberman; J Timothy Westwood; D Ashley Monks
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

7.  The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells.

Authors:  Javid A Dar; Khalid Z Masoodi; Kurtis Eisermann; Sudhir Isharwal; Junkui Ai; Laura E Pascal; Joel B Nelson; Zhou Wang
Journal:  J Steroid Biochem Mol Biol       Date:  2014-03-22       Impact factor: 4.292

8.  Transcriptional profile of muscle following acute induction of symptoms in a mouse model of Kennedy's disease/spinobulbar muscular atrophy.

Authors:  Katherine Halievski; Kaiguo Mo; J Timothy Westwood; Douglas A Monks
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

9.  Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.

Authors:  Lenore K Beitel; Carlos Alvarado; Shaza Mokhtar; Miltiadis Paliouras; Mark Trifiro
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

10.  Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy.

Authors:  Tiffany W Todd; Hiroshi Kokubu; Helen C Miranda; Constanza J Cortes; Albert R La Spada; Janghoo Lim
Journal:  Elife       Date:  2015-08-26       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.